High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome
- 1 May 1996
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 65 (5) , 961-965
- https://doi.org/10.1016/s0015-0282(16)58269-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- High doses of gonadotropins have no detrimental effect on in vitro fertilization outcome in normal respondersFertility and Sterility, 1995
- Follicle-Stimulating Hormone versus Human Menopausal Gonadotropin for in vitro Fertilization: Results of a Meta-AnalysisHormone Research, 1995
- High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transferFertility and Sterility, 1994
- Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilizationHuman Reproduction, 1991
- Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than ageFertility and Sterility, 1991
- Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization programFertility and Sterility, 1987
- Outcome of in vitro fertilization in women with low response to ovarian stimulationFertility and Sterility, 1987
- Differences in ovarian stimulation in human menopausal gonadotropin treated woman may be related to follicle-stimulating hormone accumulationFertility and Sterility, 1986